(Q53396677)

English

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

title

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

1 reference

placebo-controlled trial

1 reference

1 reference

Carl D Atkins

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

language of work or name

English

0 references

publication date

1 February 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

published in

Journal of the National Cancer Institute

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

volume

95

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

page(s)

332; author reply 333-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

Identifiers

DOI

10.1093/JNCI/95.4.332

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

PubMed publication ID

12591994

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12591994

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/12591994

ResearchGate publication ID

10895694

0 references

(Q53396677)

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)